Overview
- 6 inspections across 6 sites are on record.
- 60 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-01-28.
At a glance
Inspections
6
Sites
6
Observations
60
Career since
Apr 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Laboratorios Farmalan, S.A. | 28 Jan 2020 | Human Drugs | View 483 → |
| Baccinex Sa | 26 Jul 2019 | Human Drugs | View 483 → |
| Curia New Mexico, LLC | 15 Mar 2019 | Human Drugs | View 483 → |
| Janssen Cilag SpA | 25 Jan 2019 | Human Drugs | On file |
| GP PHARM S.A.U. | 20 Jun 2018 | Human Drugs |
Sites inspected
Laboratorios Farmalan, S.A.Villaquilambre, Spain1 insp.
Baccinex SaCourroux, Switzerland1 insp.
Curia New Mexico, LLCAlbuquerque, United States1 insp.
Janssen Cilag SpALatina, Italy1 insp.
GP PHARM S.A.U.Sant Quinti De Mediona, Spain1 insp.
Co-investigators
Investigators who share inspections with this person.
Santos E Camara2 shared
Anita Narula1 shared
Niketa Patel1 shared
Zachary A Bogorad1 shared
Yong Wang1 shared
Jose M Cayuela1 shared
Edmund F Mrak1 shared
Full investigator report
Get the verbatim findings behind Steve Y Rhieu's 60 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site